Mustafa Khasraw

Summary

Affiliation: Deakin University
Country: Australia

Publications

  1. doi request reprint Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials
    Mustafa Khasraw
    Geelong Hospital, Andrew Love Cancer Centre, 70 Swanston Street, Geelong, VIC 3220, Australia 61 3 42152700 61 3 42152836
    Expert Opin Biol Ther 14:729-40. 2014
  2. doi request reprint Emerging pharmacotherapy for cancer patients with cognitive dysfunction
    Justin Davis
    School of Medicine of Deakin University, Geelong, Vic, Australia
    BMC Neurol 13:153. 2013
  3. doi request reprint Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy
    Mustafa Khasraw
    Andrew Love Cancer Centre, Geelong Hospital, Geelong, Vic, Australia
    Expert Rev Anticancer Ther 13:451-9. 2013
  4. pmc Using lithium as a neuroprotective agent in patients with cancer
    Mustafa Khasraw
    Andrew Love Cancer Centre, Geelong Hospital, Victoria, Australia
    BMC Med 10:131. 2012
  5. doi request reprint Primary systemic therapy in HER2-amplified breast cancer: a clinical review
    Mustafa Khasraw
    School of Medicine of Deakin University, Geelong VIC 3220, Australia
    Expert Rev Anticancer Ther 12:1005-13. 2012
  6. doi request reprint Bevacizumab for the treatment of high-grade glioma
    Mustafa Khasraw
    Daekin University, Geelong Hospital, Andrew Love Cancer Centre, School of Medicine, 70 Swanston Street, Geelong VIC 3220, Australia
    Expert Opin Biol Ther 12:1101-11. 2012
  7. doi request reprint Epirubicin: is it like doxorubicin in breast cancer? A clinical review
    Mustafa Khasraw
    Andrew Love Cancer Center, Geelong Hospital, and School of Medicine of Deakin University, Geelong VIC 3220, Australia
    Breast 21:142-9. 2012

Collaborators

Detail Information

Publications7

  1. doi request reprint Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials
    Mustafa Khasraw
    Geelong Hospital, Andrew Love Cancer Centre, 70 Swanston Street, Geelong, VIC 3220, Australia 61 3 42152700 61 3 42152836
    Expert Opin Biol Ther 14:729-40. 2014
    ..Bevacizumab has also been introduced into other settings in neuro-oncology, including concurrent administration with re-irradiation for recurrent HGG. ..
  2. doi request reprint Emerging pharmacotherapy for cancer patients with cognitive dysfunction
    Justin Davis
    School of Medicine of Deakin University, Geelong, Vic, Australia
    BMC Neurol 13:153. 2013
    ....
  3. doi request reprint Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy
    Mustafa Khasraw
    Andrew Love Cancer Centre, Geelong Hospital, Geelong, Vic, Australia
    Expert Rev Anticancer Ther 13:451-9. 2013
    ..This article briefly reviews NENs before focusing on reviewing data on the role of cytotoxic chemotherapy studies in NENs...
  4. pmc Using lithium as a neuroprotective agent in patients with cancer
    Mustafa Khasraw
    Andrew Love Cancer Centre, Geelong Hospital, Victoria, Australia
    BMC Med 10:131. 2012
    ..This review discusses neurocognitive impairment in patients with cancer and the potential for investigating the use of lithium as a neuroprotectant in such patients...
  5. doi request reprint Primary systemic therapy in HER2-amplified breast cancer: a clinical review
    Mustafa Khasraw
    School of Medicine of Deakin University, Geelong VIC 3220, Australia
    Expert Rev Anticancer Ther 12:1005-13. 2012
    ....
  6. doi request reprint Bevacizumab for the treatment of high-grade glioma
    Mustafa Khasraw
    Daekin University, Geelong Hospital, Andrew Love Cancer Centre, School of Medicine, 70 Swanston Street, Geelong VIC 3220, Australia
    Expert Opin Biol Ther 12:1101-11. 2012
    ..Phase II clinical trials using bevacizumab in both newly diagnosed and recurrent high-grade glioma (HGG) showed promising results...
  7. doi request reprint Epirubicin: is it like doxorubicin in breast cancer? A clinical review
    Mustafa Khasraw
    Andrew Love Cancer Center, Geelong Hospital, and School of Medicine of Deakin University, Geelong VIC 3220, Australia
    Breast 21:142-9. 2012
    ..Short term follow up of dose-dense clinical trials demonstrated safety comparable to that of doxorubicin. This review summarizes published clinical trials investigating epirubicin in the treatment of early and advanced breast cancer...